contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


integrum-ab-integrum-partners-with-intelerad-to-streamline-surgical-planning-and-enhance-patient-outcomes-in-the-us

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Integrum is a  medical technology company. The company is developing systems for skeletal anchored prostheses based on the developed OPRA implant system, which later are being resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of many patients with amputation. The company was founded in 1998 and is headquartered in Mölndal.  

Integrum

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees, partners with Intelerad to Streamline Surgical Planning and...

<div class="abstract">Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees, partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes</div>As part of its commitment to innovation and patient care, Integrum provides custom surgical templates to its surgeon partners. These templates are tailored to each patient using three-dimensional (3D) CT scans of the patient's bone structure, based on Integrum's protocol. This meticulous process helps surgeons to ensure an optimal implant fit, ultimately leading to better outcomes for patients.The new partnership with <a style="color:#467886; text-decoration:underline" href="https://www.intelerad.com/en/">Intelerad</a>, a global leader in medical imaging software solutions, enables Integrum's customers to securely upload CT scans using <a style="color:#467886; text-decoration:underline" href="https://www.intelerad.com/en/all-products/inteleshare/">InteleShare</a>™, a HIPAA-compliant, cloud-based platform that simplifies image exchange by eliminating outdated methods and securely transferring patient data between care teams. With its vendor-neutral design, InteleShare minimizes reliance on complex on-site hardware while enhancing accessibility and operational efficiency. This streamlined communication with Integrum's Clinical Education team has significantly reduced the time required to schedule surgeries, allowing patients to receive care faster.Since the rollout of the InteleShare platform, Integrum has experienced a seamless onboarding process and successfully integrated InteleShare across its operations. The company is eager to expand this solution to all customers moving forward."We selected Intelerad's InteleShare solution because of its ability to be customized to meet our specific needs," said Jeffrey Zanni US President of Integrum Inc. "The intuitive interface makes it easy for our customers to use, and the platform has already had a measurable impact on the efficiency of our sales and surgical planning processes. We're grateful to the Intelerad team for their exceptional support during onboarding and look forward to continuing this collaboration as we enhance our customer experience and patient outcomes."This partnership underscores Integrum's dedication to leveraging cutting-edge technology to empower its surgeon partners and improve the lives of amputees worldwide."We are proud to support Integrum in transforming surgical workflows," said Intelerad's Chief Product and Technology Officer, Pete Srejovic. "InteleShare bridges gaps in healthcare by streamlining the sharing of image data, automating workflows, and simplifying the path to answers for care teams. This partnership not only enhances operational efficiency but also plays a critical role in improving patient outcomes, by ensuring timely and precise care." &nbsp;<div></div>

Integrum AB: Integrum partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes in the US